FINWIRES · TerminalLIVE
FINWIRES

Ziff Davis Q1 Adjusted Earnings, Revenue Fall; Shares Down Pre-Bell

By

-- Ziff Davis (ZD) reported Q1 adjusted earnings late Thursday of $0.73 per diluted share, down from $0.77 a year earlier.

Analysts polled by FactSet expected $0.77.

Revenue for the quarter ended March 31 was $267.6 million, down from $272.8 million a year earlier.

Analysts surveyed by FactSet expected $264.3 million.

The company said it has engaged advisers to evaluate strategic options, including the sale of its Connectivity business, and is deferring fiscal 2026 guidance as the process continues.

Shares were over 6% lower in premarket trade Friday.

Price: $40.50, Change: $-2.81, Percent Change: -6.49%

Related Articles

Asia

Anhui Fengyuan Pharmaceutical Gets China Regulatory Approval for Pediatric Constipation Drug

Anhui Fengyuan Pharmaceutical (SHE:000153) obtained drug registration from China's medical products regulator for its compound polyethylene glycol and electrolytes powder.The prescription powder is indicated for treating chronic constipation in children, according to a Friday filing with the Shenzhen bourse.The approval is valid until April 28, 2031.Shares of the company closed 1% higher Friday.

$SHE:000153
Asia

Shukra Pharmaceuticals Swings to Consolidated Loss in Fiscal Q4

Shukra Pharmaceuticals (BOM:524632) booked a consolidated net loss of 17.2 million Indian rupees in the fiscal fourth quarter ended March 31 against a profit of 53.9 million rupees a year earlier.Shares of the company fell 5% in recent trade.Loss per share stood at 0.04 rupees compared with earnings per share of 0.12 rupees a year ago, according to a Thursday filing to the Indian stock exchanges.Net sales in fiscal Q4 slipped to 63.2 million rupees from 132.7 million rupees a year prior.

$BOM:524632
Asia

RailTel Bags INR249 Million AI Fraud Detection Order from New India Assurance

RailTel Corporation of India (NSE:RAILTEL, BOM:543265) secured an order worth 249.1 million Indian rupees from The New India Assurance Company, according to a filing to the Indian stock exchanges.The contract is for the procurement of an artificial intelligence and machine learning-based solution for monitoring and investigation of fraud, waste, and abuse of health insurance claims.The order will be executed by May 6, 2029.The company's shares were down over 1% in recent trade.

$BOM:543265$NSE:RAILTEL